Physician profile
Sara M Cannon
NPI 1770594723
$1,324.90
in general payments reported to CMS, 2019-2025
21 companies · $71.76 in 2025
The $71.76 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $355 · 2020: $61.17 · 2021: $16.43 · 2022: $55.97 · 2023: $515 · 2024: $249 · 2025: $71.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $770.27 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $276.57 | 2019-2024 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $153.69 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $138.35 | 2023-2025 | Myfembree |
| Amgen INC. | $76.44 | 2019-2024 | Evenity, Prolia |
| Bayer Healthcare Pharmaceuticals INC. | $73.58 | 2019-2024 | |
| Hologic Sales and Service, LLC | $72.31 | 2019-2023 | Acessa Provu System, Coolseal Generator |
| Organon LLC | $71.65 | 2022-2024 | Nexplanon |
| Minerva Surgical, INC | $67.89 | 2019 | |
| Ethicon US, LLC | $64.03 | 2023-2024 | Ethicon, Vistaseal, Stratafix |
| Pfizer INC. | $62.33 | 2023-2024 | |
| Lsi Solutions INC | $55.21 | 2022-2024 | Running Device, Fornisee, Ti Knot |
| Exeltis, USA INC. | $51.61 | 2019-2025 | Slynd |
| Daiichi Sankyo INC. | $39.51 | 2019-2020 | |
| Biogen, INC. | $20.20 | 2025 | Zurzuvae |
| Meditrina | $16.17 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $15.65 | 2019 | |
| Novo Nordisk INC | $15.61 | 2023 | Wegovy |
| Therapeuticsmd, INC. | $14.85 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $14.79 | 2020 | |
| Aesculap, INC. | $13.60 | 2019 | |
| Lupin INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.